Device procedures described in the protocol · Sham comparator
Compensation
Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Study clarity
Things to check before joining
Study start dateStarted: October 30, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
120
Sponsor
University Hospital, Caen
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
France
Age range
From 18 Years to 65 Years
Official registry ID
NCT05550155
Official title
Show the full official title
Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment in Reducing Auditory Verbal Hallucinations (AVH) With High Frequency and Neuronavigation Guidance: A Double-blind, Randomized and Multicentric Study
Questions about this study?
The HopeStage team will email you.
Recruitment & locations
Recruiting
Caen
A listed location does not confirm current availability.
FAQ
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Caen, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.